Meropenem-clavulanate: a new strategy for the treatment of tuberculosis?

Author(s): Holzgrabe U

Affiliation(s): Institute of Pharmacy and Food Chemistry, University of Wurzburg, Am Hubland, 97074 Wurzburg, Germany. u.holzgrabe@pzlc.uni-wuerzburg.de

Publication date & source: 2009-07, ChemMedChem., 4(7):1051-3.

Publication type:

The Great White Plague: Mycobacterium tuberculosis, the bacteria causing tuberculosis, is a continuing threat to global health through the emergence of resistant strains and the lack of novel therapeutic agents. Recently reported results on this important work are highlighted.